Yellowstone Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$346K Sell
6,440
-1,785
-22% -$99K 0.2% 112
2017
Q3
$503K Buy
+8,225
New +$499K 0.26% 97
2016
Q3
$519K Buy
+8,723
New +$510K 0.19% 119
2016
Q1
Sell
-4,010
Closed -$202K 239
2015
Q4
$202K Buy
+4,010
New +$202K 0.09% 179

Other funds holding MRK

Yellowstone Partners's MRK Position: Q4 2017 in Review

Yellowstone Partners reduced its Merck (MRK) stake by 22% in Q4 2017, selling an estimated $99K and leaving 6,440 shares worth $346K. The position accounts for 0.2% of the portfolio, ranked #112.

Yellowstone Partners first reported a position in MRK in Q4 2015 and has held it in 4 quarters since. The position peaked at $519K in Q3 2016. 2,008 funds tracked by Wall St. Rank hold MRK as of Q4 2017.

  • Yellowstone Partners held 6,440 shares of Merck worth $346K as of Q4 2017.
  • Yellowstone Partners sold 1,785 Merck shares in Q4 2017, an estimated $99K.
  • Merck made up 0.2% of Yellowstone Partners's portfolio in Q4 2017, its #112 holding.
  • Yellowstone Partners first reported a position in Merck in Q4 2015 and has held it in 4 quarters since.
  • Yellowstone Partners's Merck position peaked at $519K in Q3 2016.
  • 2,008 funds tracked by Wall St. Rank held Merck as of Q4 2017.

Based on Yellowstone Partners's 13F filing for Q4 2017, filed 24 Jan 2018.